Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrenceNiki Esfahanian, Geoffrey Liu, Natasha B. Leighl et al.|Cancer Treatment and Research Communications|2023Cited by 2